Zobrazeno 1 - 10
of 64
pro vyhledávání: '"XinPing Cao"'
Autor:
YiFan Zhao, Yi Zhang, WenYi Lu, Rui Sun, RuiTing Guo, XinPing Cao, Xingzhong Liu, Cuicui Lyu, MingFeng Zhao
Publikováno v:
BMC Medical Genomics, Vol 16, Iss 1, Pp 1-14 (2023)
Abstract Background The Interferon-induced protein with tetratricopeptide repeat (IFIT) family, IFIT1/2/3/5, play an important role in different tumors progression. However, the prognosis significance and biological role of IFIT family members in acu
Externí odkaz:
https://doaj.org/article/ac90db5fd6fb4c92b77b397c57bfa0b2
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background The present study identified survival and progression-free rates and evaluated prognostic factors for IVB stage cervical cancer in patients that presented with synchronous oligometastases (sync-oligometastases) who received defini
Externí odkaz:
https://doaj.org/article/b04d32b0a3f749e0aec817f92baf629a
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 43, Iss , Pp 100690- (2023)
Purpose: Salvage treatment of recurrent cervical cancer of patients with a history of radiotherapy is currently a major clinical challenge. The purpose of our study was to retrospectively analyze clinical outcomes of radiation in patients with recurr
Externí odkaz:
https://doaj.org/article/1d9d914c77c345a989e625d024969f55
Autor:
Danni Xie, Xin Jin, Rui Sun, Meng Zhang, Wenyi Lu, Xinping Cao, Ruiting Guo, Yi Zhang, Mingfeng Zhao
Publikováno v:
Translational Oncology, Vol 34, Iss , Pp 101695- (2023)
Purpose: Acute myeloid leukemia (AML) is a highly heterogeneous neoplastic disease with a poor prognosis that relapses even after its treatment with chimeric antigen receptor (CAR)-T cells targeting a single antigen. CD123 and CLL1 are expressed in m
Externí odkaz:
https://doaj.org/article/fb0b49f90a6149baba9c49e8e3014e83
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
Autor:
Xiaojing Zheng, Haifeng Gu, Xinping Cao, Baoyue Pan, Huiling Xiang, Mingxiu Ju, Shijie Xu, Min Zheng
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundTislelizumab is an anti-programmed cell death 1 (PD-1) monoclonal antibody engineered to minimize binding to Fcγ receptors. It has been used to treat several solid tumors. However, its efficacy and toxicity, and the predictive and prognost
Externí odkaz:
https://doaj.org/article/c39575ffddd34d68b10befa2628af39c
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
With the gradual improvement of treatment regimens, the survival time of multiple myeloma (MM) patients has been significantly prolonged. Even so, MM is still a nightmare with an inferior prognosis. B-cell maturation antigen (BCMA) is highly expresse
Externí odkaz:
https://doaj.org/article/98df973b16964b67974a7eff1eb2ad97
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundIn this trial, we aimed to assess the efficacy and safety of radiotherapy with nedaplatin or cisplatin in patients with locally advanced cervical cancer.MethodsWe conducted an open-label, non-inferiority, phase III, randomized, controlled t
Externí odkaz:
https://doaj.org/article/36110399f0fe432ea2f6838e21ce4e3f
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
Objective We aimed to analyse the clinical value of primary site surgery in improving the cancer-specific survival (CSS) and overall survival (OS) of initial metastatic cervical cancer patients.Design A population-based retrospective study.Setting Na
Externí odkaz:
https://doaj.org/article/9691f188ae504e25873f90f94089e133
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Pyruvate kinase isozyme type M2 (PKM2) catalyzes the final step in glycolysis and has been found to be up-regulated in multiple human malignancies. However, whether PKM2 regulates the radiosensitivity of human cervical cancer (CC)
Externí odkaz:
https://doaj.org/article/6863cce74934485a878c8e15536e2f4a
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background To compare the efficacies and toxicities of intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy (3D-CRT) or conventional two-dimensional radiotherapy (2D-RT) for definitive treatment of cervical c
Externí odkaz:
https://doaj.org/article/d1227aa5606d4ac6ac9ffd241629538b